BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 703333 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccccc12 InChI=1S/C26H26N4O3/c1-15(31)25-18-9-5-6-10-21(18)29(28-25)14-24(32)30-22-11-17(22)12-23(30)26(33)27-20-13-19(20)16-7-3-2-4-8-16/h2-10,17,19-20,22-23H,11-14H2,1H3,(H,27,33)/t17-,19+,20-,22-,23+/m1/s1 MCCVAKOQTQVGPI-KVCDMWGSSA-N 355636 (1R,3S,5R)-2-[2-(3-Acetyl-indazol-1- yl)-acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid ((1R,2S)- 2-phenyl-cyclopropyl)-amide ::US9815819, 1 Complement factor D Human 386 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355636&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073457 386395251 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703334 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccccc12 InChI=1S/C26H26N4O3/c1-15(31)25-18-9-5-6-10-21(18)29(28-25)14-24(32)30-22-11-17(22)12-23(30)26(33)27-20-13-19(20)16-7-3-2-4-8-16/h2-10,17,19-20,22-23H,11-14H2,1H3,(H,27,33)/t17-,19+,20-,22-,23+/m1/s1 MCCVAKOQTQVGPI-KVCDMWGSSA-N 355637 (1R,3S,5R)-2-[2-(3-Acetyl-indazol-1- yl)-acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid ((1R,2S)- 2-phenyl-cyclopropyl)-amide::US9815819, 2 Complement factor D Human 29.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355637&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073457 386395252 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703335 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccncc12 InChI=1S/C25H25N5O3/c1-14(31)24-18-12-26-8-7-20(18)29(28-24)13-23(32)30-21-9-16(21)10-22(30)25(33)27-19-11-17(19)15-5-3-2-4-6-15/h2-8,12,16-17,19,21-22H,9-11,13H2,1H3,(H,27,33)/t16-,17+,19-,21-,22+/m1/s1 MYFAUORNSJANIL-VVMYPULBSA-N 355638 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[4,3-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1R,2S)-2-phenyl- cyclopropyl)-amide::US9815819, 3 Complement factor D Human 147 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355638&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073509 386395253 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703336 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2)c2cnccc12 InChI=1S/C25H25N5O3/c1-14(31)24-17-7-8-26-12-22(17)29(28-24)13-23(32)30-20-9-16(20)10-21(30)25(33)27-19-11-18(19)15-5-3-2-4-6-15/h2-8,12,16,18-21H,9-11,13H2,1H3,(H,27,33)/t16-,18-,19+,20-,21+/m1/s1 AQXXCJBRJWXMNC-RQXATKFSSA-N 355639 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1S,2R)-2-phenyl- cyclopropyl)-amide::US9815819, 4 Complement factor D Human 702 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355639&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944053 386395254 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703337 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2cnccc12 InChI=1S/C25H25N5O3/c1-14(31)24-17-7-8-26-12-22(17)29(28-24)13-23(32)30-20-9-16(20)10-21(30)25(33)27-19-11-18(19)15-5-3-2-4-6-15/h2-8,12,16,18-21H,9-11,13H2,1H3,(H,27,33)/t16-,18+,19-,20-,21+/m1/s1 AQXXCJBRJWXMNC-PPQDBTBKSA-N 355640 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1R,2S)-2-phenyl- cyclopropyl)-amide::US9815819, 5 Complement factor D Human 106 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355640&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944164 386395255 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703338 COc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC)C(N)=O InChI=1S/C27H29N5O5/c1-36-22-11-17-20(12-23(22)37-2)31(30-25(17)26(28)34)13-24(33)32-19-8-15(19)9-21(32)27(35)29-18-10-16(18)14-6-4-3-5-7-14/h3-7,11-12,15-16,18-19,21H,8-10,13H2,1-2H3,(H2,28,34)(H,29,35)/t15-,16+,18-,19-,21+/m1/s1 RLDAQYJBTXXGLB-IVADEEDNSA-N 355641 5,6-Dimethoxy-1-{2-oxo-2- [(1R,3S,5R)-3-((1R,2S)-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-ethyl}-1H- indazole-3-carboxylic acid amide::US9815819, 6 Complement factor D Human 789 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355641&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944165 386395256 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703339 COc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@H]3C[C@@H]3c3ccccc3)c2cc1OC)C(N)=O InChI=1S/C27H29N5O5/c1-36-22-11-17-20(12-23(22)37-2)31(30-25(17)26(28)34)13-24(33)32-19-8-15(19)9-21(32)27(35)29-18-10-16(18)14-6-4-3-5-7-14/h3-7,11-12,15-16,18-19,21H,8-10,13H2,1-2H3,(H2,28,34)(H,29,35)/t15-,16-,18+,19-,21+/m1/s1 RLDAQYJBTXXGLB-AJUCHXJOSA-N 355642 5,6-Dimethoxy-1-{2-oxo-2- [(1R,3S,5R)-3-((1S,2R)-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-ethyl}-1H- indazole-3-carboxylic acid amide::US9815819, 7 Complement factor D Human 4501 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355642&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019284 386395257 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703340 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ncccc12 InChI=1S/C25H25N5O3/c1-14(31)23-17-8-5-9-26-24(17)29(28-23)13-22(32)30-20-10-16(20)11-21(30)25(33)27-19-12-18(19)15-6-3-2-4-7-15/h2-9,16,18-21H,10-13H2,1H3,(H,27,33)/t16-,18+,19-,20-,21+/m1/s1 WTEZJLUANAALOQ-PPQDBTBKSA-N 355643 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0]hexane-3- carboxylic acid ((1R,2S)-2-phenyl- yclopropyl)-amide::US9815819, 8 Complement factor D Human 123 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355643&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944167 386395258 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703341 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2cnccc12 InChI=1S/C24H24N6O3/c25-23(32)22-15-6-7-26-11-20(15)29(28-22)12-21(31)30-18-8-14(18)9-19(30)24(33)27-17-10-16(17)13-4-2-1-3-5-13/h1-7,11,14,16-19H,8-10,12H2,(H2,25,32)(H,27,33)/t14-,16+,17-,18-,19+/m1/s1 QSHVHJOAMMHCCF-QTUASDBPSA-N 355644 1-{2-Oxo-2-[(1R,3S,5R)-3-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amide::US9815819, 9 Complement factor D Human 65.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355644&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944168 386395259 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703342 CO[C@@H]1[C@@H](F)CN([C@@H]1C(=O)N[C@@H]1C[C@H]1c1ccccc1)C(=O)Cn1nc(C(C)=O)c2ccccc12 InChI=1S/C26H27FN4O4/c1-15(32)23-17-10-6-7-11-21(17)31(29-23)14-22(33)30-13-19(27)25(35-2)24(30)26(34)28-20-12-18(20)16-8-4-3-5-9-16/h3-11,18-20,24-25H,12-14H2,1-2H3,(H,28,34)/t18-,19-,20+,24-,25+/m0/s1 QPVHNTLUUHCFCQ-NXBKFZNKSA-N 355645 (2S,3S,4S)-1-[2-(3-Acetyl-indazol-1- yl)-acetyl]-4-fluoro-3-methoxy- pyrrolidine-2-carboxylic acid ((1R,2S)-2-phenyl-cyclopropyl)- amide::US9815819, 10 Complement factor D Human 40.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355645&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944274 386395260 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703343 COc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC)C(C)=O InChI=1S/C28H30N4O5/c1-15(33)27-19-12-24(36-2)25(37-3)13-22(19)31(30-27)14-26(34)32-21-9-17(21)10-23(32)28(35)29-20-11-18(20)16-7-5-4-6-8-16/h4-8,12-13,17-18,20-21,23H,9-11,14H2,1-3H3,(H,29,35)/t17-,18+,20-,21-,23+/m1/s1 GVWDBPAOIXLRBN-DUIOMNELSA-N 355646 (1R,3S,5R)-2-[2-(3-Acetyl-5,6- dimethoxy-indazol-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid ((1R,2S)-2-phenyl- cyclopropyl)-amide::US9815819, 11 Complement factor D Human 226 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355646&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944275 386395261 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703344 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccccc12 InChI=1S/C25H25N5O3/c26-24(32)23-16-8-4-5-9-19(16)29(28-23)13-22(31)30-20-10-15(20)11-21(30)25(33)27-18-12-17(18)14-6-2-1-3-7-14/h1-9,15,17-18,20-21H,10-13H2,(H2,26,32)(H,27,33)/t15-,17+,18-,20-,21+/m1/s1 RZCSWCSEYQUVRA-APOUVHJUSA-N 355647 1-{2-Oxo-2-[(1R,3S,5R)-3-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-indazole-3-carboxylic acid amide::US9815819, 12 Complement factor D Human 60.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355647&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944276 386395262 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703345 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ncccc12 InChI=1S/C24H24N6O3/c25-22(32)21-15-7-4-8-26-23(15)29(28-21)12-20(31)30-18-9-14(18)10-19(30)24(33)27-17-11-16(17)13-5-2-1-3-6-13/h1-8,14,16-19H,9-12H2,(H2,25,32)(H,27,33)/t14-,16+,17-,18-,19+/m1/s1 QXNIYAKFRFOQEB-QTUASDBPSA-N 355648 1-{2-Oxo-2-[(1R,3S,5R)-3-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-b]pyridine-3- carboxylic acid amide::US9815819, 13 Complement factor D Human 172 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355648&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944277 386395263 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703346 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccncc12 InChI=1S/C24H24N6O3/c25-23(32)22-16-11-26-7-6-18(16)29(28-22)12-21(31)30-19-8-14(19)9-20(30)24(33)27-17-10-15(17)13-4-2-1-3-5-13/h1-7,11,14-15,17,19-20H,8-10,12H2,(H2,25,32)(H,27,33)/t14-,15+,17-,19-,20+/m1/s1 WBYBUFLRFACTLF-XCVIRLNASA-N 355649 1-{2-Oxo-2-[(1R,3S,5R)-3-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[4,3-c]pyridine-3- carboxylic acid amide::US9815819, 14 Complement factor D Human 118 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355649&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944278 386395264 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703347 Cc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3)c2cn1)C(N)=O InChI=1S/C25H26N6O3/c1-13-7-17-21(11-27-13)30(29-23(17)24(26)33)12-22(32)31-19-8-15(19)9-20(31)25(34)28-18-10-16(18)14-5-3-2-4-6-14/h2-7,11,15-16,18-20H,8-10,12H2,1H3,(H2,26,33)(H,28,34)/t15-,16+,18-,19-,20+/m1/s1 DHTZZSXUNMIQHB-LHDHZVESSA-N 355650 5-Methyl-1-{2-oxo-2-[(1R,3S,5R)-3- ((1R,2S)-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-ethyl}-1H- pyrazolo[3,4-]pyridine-3-carboxylic acid amide::US9815819, 15 Complement factor D Human 115 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355650&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944377 386395265 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703348 NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccncc12 InChI=1S/C23H23FN6O3/c24-14-8-19(23(33)27-17-9-15(17)13-4-2-1-3-5-13)29(11-14)20(31)12-30-18-6-7-26-10-16(18)21(28-30)22(25)32/h1-7,10,14-15,17,19H,8-9,11-12H2,(H2,25,32)(H,27,33)/t14-,15+,17-,19+/m1/s1 MFWORQVATQRTAU-GFIVTLFCSA-N 355651 1-{2-[(2S,4R)-4-Fluoro-2-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)- pyrrolidin-1-yl]-2-oxo-ethyl}-1H- pyrazolo[4,3-c]pyridine-3-carboxylic acid amide::US9815819, 16 Complement factor D Human 1238 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355651&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944378 386395266 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703349 NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ncccc12 InChI=1S/C23H23FN6O3/c24-14-9-18(23(33)27-17-10-16(17)13-5-2-1-3-6-13)29(11-14)19(31)12-30-22-15(7-4-8-26-22)20(28-30)21(25)32/h1-8,14,16-18H,9-12H2,(H2,25,32)(H,27,33)/t14-,16+,17-,18+/m1/s1 OLGCKPIRUWFBSE-SPUZQDLCSA-N 355652 1-{2-[(2S,4R)-4-Fluoro-2-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)- pyrrolidin-1-yl]-2-oxo-ethyl}-1H- pyrazolo[3,4-b]pyridine-3-carboxylic acid amide::US9815819, 17 Complement factor D Human 117 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355652&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944379 386395267 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703350 NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccccc12 InChI=1S/C24H24FN5O3/c25-15-10-20(24(33)27-18-11-17(18)14-6-2-1-3-7-14)29(12-15)21(31)13-30-19-9-5-4-8-16(19)22(28-30)23(26)32/h1-9,15,17-18,20H,10-13H2,(H2,26,32)(H,27,33)/t15-,17+,18-,20+/m1/s1 NMJRIUGLMDYYJW-QEEHTWDDSA-N 355653 1-{2-[(2S,4R)-4-Fluoro-2-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)- pyrrolidin-1-yl]-2-oxo-ethyl}-1H- indazole-3-carboxylic acid amide::US9815819, 18 Complement factor D Human 44.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355653&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944380 386395268 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703351 CCc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3)c2cn1)C(N)=O InChI=1S/C26H28N6O3/c1-2-16-10-18-22(12-28-16)31(30-24(18)25(27)34)13-23(33)32-20-8-15(20)9-21(32)26(35)29-19-11-17(19)14-6-4-3-5-7-14/h3-7,10,12,15,17,19-21H,2,8-9,11,13H2,1H3,(H2,27,34)(H,29,35)/t15-,17+,19-,20-,21+/m1/s1 CKXZLAHTVLRGOW-AQDHKIAYSA-N 355654 5-Ethyl-1-{2-oxo-2-[(1R,3S,5R)-3- ((1R,2S)-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-ethyl}-1H- pyrazolo[3,4-c]pyridine-3-carboxylic acid amide::US9815819, 19 Complement factor D Human 31.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355654&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944381 386395269 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703352 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2cc3OCCOc3cc12 InChI=1S/C27H27N5O5/c28-26(34)25-17-11-22-23(37-7-6-36-22)12-20(17)31(30-25)13-24(33)32-19-8-15(19)9-21(32)27(35)29-18-10-16(18)14-4-2-1-3-5-14/h1-5,11-12,15-16,18-19,21H,6-10,13H2,(H2,28,34)(H,29,35)/t15-,16+,18-,19-,21+/m1/s1 JBBSYSZIYJEEDL-IVADEEDNSA-N 355655 1-{2-Oxo-2-[(1R,3S,5R)-3-((1R,2S)- 2-phenyl-cyclopropylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 6,7-dihydro-1H-5,8-dioxa-1,2-diaza- cyclopenta[b]naphthalene-3- carboxylic acid amide::US9815819, 20 Complement factor D Human 368 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355655&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944486 386395270 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703353 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2Cl)c2cnccc12 InChI=1S/C24H23ClN6O3/c25-16-4-2-1-3-13(16)15-9-17(15)28-24(34)19-8-12-7-18(12)31(19)21(32)11-30-20-10-27-6-5-14(20)22(29-30)23(26)33/h1-6,10,12,15,17-19H,7-9,11H2,(H2,26,33)(H,28,34)/t12-,15-,17+,18-,19+/m1/s1 SRUVQNXKBMRRSH-LRTZBTEVSA-N 355656 1-(2-{(1R,3S,5R)-3-[(1S,2R)-2-(2- Chloro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amide::US9815819, 21 Complement factor D Human 1402 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355656&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019594 386395271 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703354 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@]2(C)C[C@H]2c2ccccc2)c2cnccc12 InChI=1S/C26H27N5O3/c1-15(32)24-18-8-9-27-13-22(18)30(29-24)14-23(33)31-20-10-17(20)11-21(31)25(34)28-26(2)12-19(26)16-6-4-3-5-7-16/h3-9,13,17,19-21H,10-12,14H2,1-2H3,(H,28,34)/t17-,19+,20-,21+,26-/m1/s1 OSXWYPHJWLWEDQ-HWQSGAIWSA-N 355657 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1R,2S)-1-methyl-2- phenyl-cyclopropyl)-amide::US9815819, 22 Complement factor D Human 870 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355657&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944488 386395272 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703355 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@]2(C)C[C@@H]2c2ccccc2)c2cnccc12 InChI=1S/C26H27N5O3/c1-15(32)24-18-8-9-27-13-22(18)30(29-24)14-23(33)31-20-10-17(20)11-21(31)25(34)28-26(2)12-19(26)16-6-4-3-5-7-16/h3-9,13,17,19-21H,10-12,14H2,1-2H3,(H,28,34)/t17-,19-,20-,21+,26+/m1/s1 OSXWYPHJWLWEDQ-WYAAMRIOSA-N 355658 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1S,2R)-1-methyl-2- phenyl-cyclopropyl)-amide::US9815819, 23 Complement factor D Human 13151 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355658&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073498 386395273 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703356 C[C@@]1(C[C@@H]1c1ccccc1)NC(=O)[C@@H]1C[C@H]2C[C@H]2N1C(=O)Cn1nc(C(N)=O)c2ccccc12 InChI=1S/C26H27N5O3/c1-26(13-18(26)15-7-3-2-4-8-15)28-25(34)21-12-16-11-20(16)31(21)22(32)14-30-19-10-6-5-9-17(19)23(29-30)24(27)33/h2-10,16,18,20-21H,11-14H2,1H3,(H2,27,33)(H,28,34)/t16-,18-,20-,21+,26+/m1/s1 WPXKQPSTGQRLOF-AAVJGEJYSA-N 355659 1-{2-[(1R,3S,5R)-3-((1S,2R)-1- Methyl-2-phenyl-cyclopropyl- carbamoyl)-2-aza-bicyclo[3.1.0]hex- 2-yl]-2-oxo-ethyl}-1H-indazole-3- carboxylic acid amide::US9815819, 24 Complement factor D Human 17592 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355659&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944490 386395274 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703357 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2cc(F)c(F)cc12 InChI=1S/C25H22F3N5O3/c26-15-8-14-18(9-16(15)27)32(31-22(14)23(29)35)11-21(34)33-17-6-12(17)7-19(33)24(36)30-20-10-25(20,28)13-4-2-1-3-5-13/h1-5,8-9,12,17,19-20H,6-7,10-11H2,(H2,29,35)(H,30,36)/t12-,17-,19+,20-,25-/m1/s1 MLIVZKWUZBVHCL-JTCLPYQVSA-N 355660 5,6-Difluoro-1-{2-[(1R,3S,5R)-3- ((1R,2R)-2-fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 1H-indazole-3-carboxylic acid amide::US9815819, 25 Complement factor D Human 110 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355660&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944598 386395275 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703358 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2ccc(F)cc12 InChI=1S/C25H23F2N5O3/c26-15-6-7-17-16(10-15)22(23(28)34)30-31(17)12-21(33)32-18-8-13(18)9-19(32)24(35)29-20-11-25(20,27)14-4-2-1-3-5-14/h1-7,10,13,18-20H,8-9,11-12H2,(H2,28,34)(H,29,35)/t13-,18-,19+,20-,25-/m1/s1 HPYWMOGYCYXTQI-WGSUTQFOSA-N 355661 5-Fluoro-1-{2-[(1R,3S,5R)-3- ((1R,2R)-2-fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 1H-indazole-3-carboxylic acid amide::US9815819, 26 Complement factor D Human 60.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355661&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944599 386395276 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703359 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2ccc(Cl)cc12 InChI=1S/C25H23ClFN5O3/c26-15-6-7-17-16(10-15)22(23(28)34)30-31(17)12-21(33)32-18-8-13(18)9-19(32)24(35)29-20-11-25(20,27)14-4-2-1-3-5-14/h1-7,10,13,18-20H,8-9,11-12H2,(H2,28,34)(H,29,35)/t13-,18-,19+,20-,25-/m1/s1 UFDUIRTWZUTGCU-WGSUTQFOSA-N 355662 5-Chloro-1-{2-[(1R,3S,5R)-3- ((1R,2R)-2-fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 1H-indazole-3-carboxylic acid amide::US9815819, 27 Complement factor D Human 119 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355662&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944600 386395277 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703360 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CO)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ncccc12 InChI=1S/C26H27N5O4/c1-15(33)23-17-8-5-9-27-24(17)30(29-23)13-22(34)31-20(11-26(14-32)12-21(26)31)25(35)28-19-10-18(19)16-6-3-2-4-7-16/h2-9,18-21,32H,10-14H2,1H3,(H,28,35)/t18-,19+,20-,21+,26-/m0/s1 LZWDGXJBRKBDLW-XXDCYXHNSA-N 355663 (1R,3S,5S)-2-[2-(3-Acetyl-pyrazolo[3,4-b]pyridin-1-yl)-acetyl]-5-hydroxymethyl-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid((1R,2S)-2-phenyl-cyclopropyl)-amide::US9815819, 28 Complement factor D Human 172 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355663&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944601 386395278 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703361 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CO)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2cnccc12 InChI=1S/C26H27N5O4/c1-15(33)24-17-7-8-27-12-21(17)30(29-24)13-23(34)31-20(10-26(14-32)11-22(26)31)25(35)28-19-9-18(19)16-5-3-2-4-6-16/h2-8,12,18-20,22,32H,9-11,13-14H2,1H3,(H,28,35)/t18-,19+,20-,22+,26-/m0/s1 WKZXIBOLTMFMGE-UILVKNMWSA-N 355664 (1R,3S,5S)-2-[2-(3-Acetyl-pyrazolo[3,4-c]pyridin-1-yl)-acetyl]-5-hydroxymethyl-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid((1R,2S)-2-phenyl-cyclopropyl)-amide::US9815819, 29 Complement factor D Human 119 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355664&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944602 386395279 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703362 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CO)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2ccccc12 InChI=1S/C26H26ClN5O4/c27-17-7-3-1-5-14(17)16-9-18(16)29-25(36)20-10-26(13-33)11-21(26)32(20)22(34)12-31-19-8-4-2-6-15(19)23(30-31)24(28)35/h1-8,16,18,20-21,33H,9-13H2,(H2,28,35)(H,29,36)/t16-,18+,20-,21+,26-/m0/s1 DQNUMVJDICOFNS-SUQPLWHDSA-N 355665 1-(2-{(1R,3S,5S)-3-[(1R,2S)-2-(2-Chloro-phenyl)-cyclopropylcarbamoyl]-5-hydroxymethyl-2-aza-bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)-1H-indazole-3-carboxylic acid amide::US9815819, 30 Complement factor D Human 22.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355665&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72705618 386395280 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703363 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CO)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2cnccc12 InChI=1S/C26H26ClN5O4/c1-14(34)24-16-6-7-28-11-21(16)31(30-24)12-23(35)32-20(9-26(13-33)10-22(26)32)25(36)29-19-8-17(19)15-4-2-3-5-18(15)27/h2-7,11,17,19-20,22,33H,8-10,12-13H2,1H3,(H,29,36)/t17-,19+,20-,22+,26-/m0/s1 WAGLKNINCOVDGO-JTLGYDTDSA-N 355666 (1R,3S,5S)-2-[2-(3-Acetyl-pyrazolo[3,4-c]pyridin-1-yl)-acetyl]-5-hydroxymethyl-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid[(1R,2S)-2-(2-chloro-phenyl)-cyclopropyl]-amide::US9815819, 31 Complement factor D Human 37.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355666&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944705 386395281 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703364 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2cccc(c2)C(F)F)c2cnccc12 InChI=1S/C26H25F2N5O3/c1-13(34)24-17-5-6-29-11-22(17)32(31-24)12-23(35)33-20-8-16(20)9-21(33)26(36)30-19-10-18(19)14-3-2-4-15(7-14)25(27)28/h2-7,11,16,18-21,25H,8-10,12H2,1H3,(H,30,36)/t16-,18?,19?,20-,21+/m1/s1 IKVNINDMAFUDAC-PATRTNIUSA-N 355667 US9815819, 32 Complement factor D Human 326 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355667&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 139268621 386395282 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703365 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2cccc(c2)C(F)(F)F)c2cnccc12 InChI=1S/C26H24F3N5O3/c1-13(35)24-17-5-6-30-11-22(17)33(32-24)12-23(36)34-20-8-15(20)9-21(34)25(37)31-19-10-18(19)14-3-2-4-16(7-14)26(27,28)29/h2-7,11,15,18-21H,8-10,12H2,1H3,(H,31,37)/t15-,18?,19?,20-,21+/m1/s1 MFVCZUMCNOQGPI-BOGMBQSFSA-N 355668 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid [2-(3- trifluoromethyl-phenyl)- cyclopropyl]-amide (mixture of 4 diastereomers)::US9815819, 33 Complement factor D Human 550 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355668&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90020540 386395283 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703366 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2ccc(C)c(C)c2)c2cnccc12 InChI=1S/C27H29N5O3/c1-14-4-5-17(8-15(14)2)20-11-21(20)29-27(35)23-10-18-9-22(18)32(23)25(34)13-31-24-12-28-7-6-19(24)26(30-31)16(3)33/h4-8,12,18,20-23H,9-11,13H2,1-3H3,(H,29,35)/t18-,20?,21?,22-,23+/m1/s1 SJIJYQMSZNZJHL-BQJFXGIPSA-N 355669 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid [2-(3,4- dimethyl-phenyl)-cyclopropyl]- amide (mixture of 4 diastereomers)::US9815819, 34 Complement factor D Human 112 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355669&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90020270 386395284 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703367 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC(C2)c2ccccc2)c2ncccc12 InChI=1S/C26H27N5O3/c1-15(32)24-20-8-5-9-27-25(20)30(29-24)14-23(33)31-21-12-18(21)13-22(31)26(34)28-19-10-17(11-19)16-6-3-2-4-7-16/h2-9,17-19,21-22H,10-14H2,1H3,(H,28,34)/t17?,18-,19?,21-,22+/m1/s1 KQWNJGIWGQWZLL-IRCYLWAESA-N 355670 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid (3- phenyl-cyclobutyl)-amide (mixture of 4 diastereomers)::US9815819, 35 Complement factor D Human 902 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355670&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944802 386395285 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703368 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC(C2)c2ccccc2F)c2ncccc12 InChI=1S/C26H26FN5O3/c1-14(33)24-19-6-4-8-28-25(19)31(30-24)13-23(34)32-21-11-16(21)12-22(32)26(35)29-17-9-15(10-17)18-5-2-3-7-20(18)27/h2-8,15-17,21-22H,9-13H2,1H3,(H,29,35)/t15?,16-,17?,21-,22+/m1/s1 UXYISJTVGXUHFY-GRSRJZHPSA-N 355671 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid [3-(2- fluoro-phenyl)-cyclobutyl]-amide (mixture of 4 diastereomers)::US9815819, 36 Complement factor D Human 466 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355671&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944803 386395286 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703369 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCC(CC2)c2ccccc2)c2cnccc12 InChI=1S/C28H31N5O3/c1-17(34)27-22-11-12-29-15-25(22)32(31-27)16-26(35)33-23-13-20(23)14-24(33)28(36)30-21-9-7-19(8-10-21)18-5-3-2-4-6-18/h2-6,11-12,15,19-21,23-24H,7-10,13-14,16H2,1H3,(H,30,36)/t19?,20-,21?,23-,24+/m1/s1 UAFFXDLJFUJSSN-PJDSQXTCSA-N 355672 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid (4- phenyl-cyclohexyl)-amide (mixture of diastereomers)::US9815819, 37 Complement factor D Human 1055 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355672&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944804 386395287 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703370 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@]2(F)c2ccccc2)c2ccccc12 InChI=1S/C25H24FN5O3/c26-25(15-6-2-1-3-7-15)12-20(25)28-24(34)19-11-14-10-18(14)31(19)21(32)13-30-17-9-5-4-8-16(17)22(29-30)23(27)33/h1-9,14,18-20H,10-13H2,(H2,27,33)(H,28,34)/t14-,18-,19+,20+,25+/m1/s1 TUONQBRSRDDMDZ-XZJLILLNSA-N 355673 1-{2-[(1R,3S,5R)-3-((1S,2S)-2-fluoro-2-phenyl-cyclopropylcarbamoyl)-2-aza-bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}-1H-indazole-3-carboxylic acid amide::US9815819, 38 Complement factor D Human 635 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355673&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944805 386395288 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703371 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2ccccc12 InChI=1S/C25H24FN5O3/c26-25(15-6-2-1-3-7-15)12-20(25)28-24(34)19-11-14-10-18(14)31(19)21(32)13-30-17-9-5-4-8-16(17)22(29-30)23(27)33/h1-9,14,18-20H,10-13H2,(H2,27,33)(H,28,34)/t14-,18-,19+,20-,25-/m1/s1 TUONQBRSRDDMDZ-VFXCVLQMSA-N 355674 1-{2-[(1R,3S,5R)-3-((1R,2R)-2-fluoro-2-phenyl-cyclopropylcarbamoyl)-2-aza-bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}-1H-indazole-3-carboxylic acid amide ::US9815819, 39 Complement factor D Human 48.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355674&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944806 386395289 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703372 NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2F)c2cnccc12 InChI=1S/C23H22F2N6O3/c24-12-7-18(23(34)28-17-8-15(17)13-3-1-2-4-16(13)25)30(10-12)20(32)11-31-19-9-27-6-5-14(19)21(29-31)22(26)33/h1-6,9,12,15,17-18H,7-8,10-11H2,(H2,26,33)(H,28,34)/t12-,15+,17-,18+/m1/s1 ATGUPDKNZUNTJL-XGWTYTTDSA-N 355675 1-(2-{(2S,4R)-4-Fluoro-2-[(1R,2S)- 2-(2-fluoro-phenyl)- cyclopropylcarbamoyl]-pyrrolidin-1- yl}-2-oxo-ethyl)-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 40 Complement factor D Human 142 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355675&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944904 386395290 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703373 NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2F)c2cnccc12 InChI=1S/C23H22F2N6O3/c24-12-7-18(23(34)28-17-8-15(17)13-3-1-2-4-16(13)25)30(10-12)20(32)11-31-19-9-27-6-5-14(19)21(29-31)22(26)33/h1-6,9,12,15,17-18H,7-8,10-11H2,(H2,26,33)(H,28,34)/t12-,15-,17+,18+/m1/s1 ATGUPDKNZUNTJL-ZYUBPSHWSA-N 355676 1-(2-{(2S,4R)-4-Fluoro-2-[(1S,2R)- 2-(2-fluoro-phenyl)- cyclopropylcarbamoyl]-pyrrolidin-1- yl}-2-oxo-ethyl)-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 41 Complement factor D Human 1188 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355676&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944905 386395291 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703374 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@]2(F)c2ccccc2)c2cnccc12 InChI=1S/C24H23FN6O3/c25-24(14-4-2-1-3-5-14)10-19(24)28-23(34)17-9-13-8-16(13)31(17)20(32)12-30-18-11-27-7-6-15(18)21(29-30)22(26)33/h1-7,11,13,16-17,19H,8-10,12H2,(H2,26,33)(H,28,34)/t13-,16-,17+,19+,24+/m1/s1 YSHYEVNFHXZBHT-XVDZJIRASA-N 355677 1-{2-[(1R,3S,5R)-3-((1S,2S)-2- Fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amide::US9815819, 42 Complement factor D Human 3652 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355677&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944906 386395292 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703375 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2cnccc12 InChI=1S/C24H23FN6O3/c25-24(14-4-2-1-3-5-14)10-19(24)28-23(34)17-9-13-8-16(13)31(17)20(32)12-30-18-11-27-7-6-15(18)21(29-30)22(26)33/h1-7,11,13,16-17,19H,8-10,12H2,(H2,26,33)(H,28,34)/t13-,16-,17+,19-,24-/m1/s1 YSHYEVNFHXZBHT-RYHISXGPSA-N 355678 1-{2-[(1R,3S,5R)-3-((1R,2R)-2- Fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amide::US9815819, 43 Complement factor D Human 214 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355678&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944907 386395293 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703376 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2ncccc12 InChI=1S/C25H24FN5O3/c1-14(32)22-17-8-5-9-27-23(17)30(29-22)13-21(33)31-18-10-15(18)11-19(31)24(34)28-20-12-25(20,26)16-6-3-2-4-7-16/h2-9,15,18-20H,10-13H2,1H3,(H,28,34)/t15-,18-,19+,20-,25-/m1/s1 DFKWZGIUBHZQJS-LBRQCZJCSA-N 355679 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1R,2R)-2-fluoro-2- phenyl-cyclopropyl)-amide::US9815819, 44 Complement factor D Human 66.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355679&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943225 386395294 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703377 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@]2(F)c2ccccc2)c2ncccc12 InChI=1S/C25H24FN5O3/c1-14(32)22-17-8-5-9-27-23(17)30(29-22)13-21(33)31-18-10-15(18)11-19(31)24(34)28-20-12-25(20,26)16-6-3-2-4-7-16/h2-9,15,18-20H,10-13H2,1H3,(H,28,34)/t15-,18-,19+,20+,25+/m1/s1 DFKWZGIUBHZQJS-ZPTNXYKCSA-N 355680 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1S,2S)-2-fluoro-2- phenyl-cyclopropyl)-amide::US9815819, 45 Complement factor D Human 10359 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355680&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72944908 386395295 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703378 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@@]2(F)c2ccccc2)c2cnccc12 InChI=1S/C25H24FN5O3/c1-14(32)23-17-7-8-27-12-20(17)30(29-23)13-22(33)31-18-9-15(18)10-19(31)24(34)28-21-11-25(21,26)16-5-3-2-4-6-16/h2-8,12,15,18-19,21H,9-11,13H2,1H3,(H,28,34)/t15-,18-,19+,21-,25-/m1/s1 WMOWJWBDTFNQOQ-MERPOFQFSA-N 355681 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1R,2R)-2-fluoro-2- phenyl-cyclopropyl)-amide::US9815819, 46 Complement factor D Human 32.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355681&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943226 386395296 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703379 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@]2(F)c2ccccc2)c2cnccc12 InChI=1S/C25H24FN5O3/c1-14(32)23-17-7-8-27-12-20(17)30(29-23)13-22(33)31-18-9-15(18)10-19(31)24(34)28-21-11-25(21,26)16-5-3-2-4-6-16/h2-8,12,15,18-19,21H,9-11,13H2,1H3,(H,28,34)/t15-,18-,19+,21+,25+/m1/s1 WMOWJWBDTFNQOQ-RODWNUBWSA-N 355682 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid ((1S,2S)-2-fluoro-2- phenyl-cyclopropyl)-amide::US9815819, 47 Complement factor D Human 991 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355682&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90027911 386395297 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703380 Cc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@@]3(F)c3ccccc3)c2cn1)C(N)=O InChI=1S/C25H25FN6O3/c1-13-7-16-19(11-28-13)31(30-22(16)23(27)34)12-21(33)32-17-8-14(17)9-18(32)24(35)29-20-10-25(20,26)15-5-3-2-4-6-15/h2-7,11,14,17-18,20H,8-10,12H2,1H3,(H2,27,34)(H,29,35)/t14-,17-,18+,20-,25-/m1/s1 QWLHKEAOEMFIQW-PAZNCINKSA-N 355683 1-{2-[(1R,3S,5R)-3-((1R,2R)-2- Fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 5-methyl-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 48 Complement factor D Human 30.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355683&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943228 386395298 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703381 Cc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@H]3C[C@]3(F)c3ccccc3)c2cn1)C(N)=O InChI=1S/C25H25FN6O3/c1-13-7-16-19(11-28-13)31(30-22(16)23(27)34)12-21(33)32-17-8-14(17)9-18(32)24(35)29-20-10-25(20,26)15-5-3-2-4-6-15/h2-7,11,14,17-18,20H,8-10,12H2,1H3,(H2,27,34)(H,29,35)/t14-,17-,18+,20+,25+/m1/s1 QWLHKEAOEMFIQW-NFGFWRJKSA-N 355684 1-{2-[(1R,3S,5R)-3-((1S,2S)-2- Fluoro-2-phenyl- cyclopropylcarbamoyl)-2-aza- bicyclo[3.1.0]hex-2-yl]-2-oxo-ethyl}- 5-methyl-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 49 Complement factor D Human 1186 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355684&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019359 386395299 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703382 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2(F)c2ccccc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-16-7-3-2-6-15(16)25(27)11-20(25)29-24(35)19-10-13-9-18(13)32(19)21(33)12-31-17-8-4-1-5-14(17)22(30-31)23(28)34/h1-8,13,18-20H,9-12H2,(H2,28,34)(H,29,35)/t13-,18-,19+,20?,25?/m1/s1 OSOOTYFTZSZVJQ-MLZGNOHJSA-N 355685 1-(2-{(1R,3S,5R)-3-[2-Fluoro-2-(2- fluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 50::US9815819, 51::US9815819, 52::US9815819, 53 Complement factor D Human 3879 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355685&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943339 386395300 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703383 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2(F)c2ccccc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-16-7-3-2-6-15(16)25(27)11-20(25)29-24(35)19-10-13-9-18(13)32(19)21(33)12-31-17-8-4-1-5-14(17)22(30-31)23(28)34/h1-8,13,18-20H,9-12H2,(H2,28,34)(H,29,35)/t13-,18-,19+,20?,25?/m1/s1 OSOOTYFTZSZVJQ-MLZGNOHJSA-N 355685 1-(2-{(1R,3S,5R)-3-[2-Fluoro-2-(2- fluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 50::US9815819, 51::US9815819, 52::US9815819, 53 Complement factor D Human 992 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355685&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943339 386395300 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703384 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2(F)c2ccccc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-16-7-3-2-6-15(16)25(27)11-20(25)29-24(35)19-10-13-9-18(13)32(19)21(33)12-31-17-8-4-1-5-14(17)22(30-31)23(28)34/h1-8,13,18-20H,9-12H2,(H2,28,34)(H,29,35)/t13-,18-,19+,20?,25?/m1/s1 OSOOTYFTZSZVJQ-MLZGNOHJSA-N 355685 1-(2-{(1R,3S,5R)-3-[2-Fluoro-2-(2- fluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 50::US9815819, 51::US9815819, 52::US9815819, 53 Complement factor D Human 367 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355685&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943339 386395300 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703385 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2(F)c2ccccc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-16-7-3-2-6-15(16)25(27)11-20(25)29-24(35)19-10-13-9-18(13)32(19)21(33)12-31-17-8-4-1-5-14(17)22(30-31)23(28)34/h1-8,13,18-20H,9-12H2,(H2,28,34)(H,29,35)/t13-,18-,19+,20?,25?/m1/s1 OSOOTYFTZSZVJQ-MLZGNOHJSA-N 355685 1-(2-{(1R,3S,5R)-3-[2-Fluoro-2-(2- fluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 50::US9815819, 51::US9815819, 52::US9815819, 53 Complement factor D Human 36.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355685&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943339 386395300 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703386 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2cccc(Cl)c2)c2ncccc12 InChI=1S/C25H24ClN5O3/c1-13(32)23-17-6-3-7-27-24(17)30(29-23)12-22(33)31-20-9-15(20)10-21(31)25(34)28-19-11-18(19)14-4-2-5-16(26)8-14/h2-8,15,18-21H,9-12H2,1H3,(H,28,34)/t15-,18+,19-,20-,21+/m1/s1 ILVYIAYQOASYTJ-XTSANDPQSA-N 355689 (1R,3S,5R)-2-[2-(3-Acetyl-pyrazolo[3,4-b]pyridin-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid [(1R,2S)-2-(3-chloro-phenyl)-cyclopropyl]-amide::US9815819, 54 Complement factor D Human 225 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355689&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943341 386395301 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703387 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@@H]2c2cccc(Cl)c2)c2ncccc12 InChI=1S/C25H24ClN5O3/c1-13(32)23-17-6-3-7-27-24(17)30(29-23)12-22(33)31-20-9-15(20)10-21(31)25(34)28-19-11-18(19)14-4-2-5-16(26)8-14/h2-8,15,18-21H,9-12H2,1H3,(H,28,34)/t15-,18-,19+,20-,21+/m1/s1 ILVYIAYQOASYTJ-GRARQNNCSA-N 355690 (1R,3S,5R)-2-[2-(3-acetyl-pyrazolo[3,4-b]pyridin-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carboxylic acid[(1S,2R)-2-(3-chloro-phenyl)-cyclopropyl]-amide ::US9815819, 55 Complement factor D Human 1575 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355690&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943340 386395302 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703388 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2cccc(Cl)c2F)c2ncccc12 InChI=1S/C25H23ClFN5O3/c1-12(33)23-15-5-3-7-28-24(15)31(30-23)11-21(34)32-19-8-13(19)9-20(32)25(35)29-18-10-16(18)14-4-2-6-17(26)22(14)27/h2-7,13,16,18-20H,8-11H2,1H3,(H,29,35)/t13-,16+,18-,19-,20+/m1/s1 LBWPZVPJDVHPME-MKCULMFZSA-N 355691 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0]hexane-3- carboxylic acid [(1R,2S)-2-(3- chloro-2-fluoro-phenyl)- cyclopropyl]-amide::US9815819, 56 Complement factor D Human 109 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355691&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943342 386395303 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703389 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@@H]2c2cccc(Cl)c2F)c2ncccc12 InChI=1S/C25H23ClFN5O3/c1-12(33)23-15-5-3-7-28-24(15)31(30-23)11-21(34)32-19-8-13(19)9-20(32)25(35)29-18-10-16(18)14-4-2-6-17(26)22(14)27/h2-7,13,16,18-20H,8-11H2,1H3,(H,29,35)/t13-,16-,18+,19-,20+/m1/s1 LBWPZVPJDVHPME-NLMIBYRWSA-N 355692 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0]hexane-3- carboxylic acid [(1S,2R)-2-(3- chloro-2-fluoro-phenyl)- cyclopropyl]-amide::US9815819, 57 Complement factor D Human 1614 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355692&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943343 386395304 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703390 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2ccccc12 InChI=1S/C25H24ClN5O3/c26-17-7-3-1-5-14(17)16-11-18(16)28-25(34)21-10-13-9-20(13)31(21)22(32)12-30-19-8-4-2-6-15(19)23(29-30)24(27)33/h1-8,13,16,18,20-21H,9-12H2,(H2,27,33)(H,28,34)/t13-,16+,18-,20-,21+/m1/s1 UXVZINSCKZBLGX-LGMZZFRSSA-N 355693 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2-Chloro-phenyl)-cyclopropylcarbamoyl]-2-aza-bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)-1H-indazole-3-carboxylic acid amide::US9815819, 58 Complement factor D Human 39.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355693&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90020177 386395305 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703391 CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccccc12 InChI=1S/C25H25FN4O3/c1-15(31)24-18-9-5-6-10-21(18)30(28-24)14-23(32)29-13-17(26)11-22(29)25(33)27-20-12-19(20)16-7-3-2-4-8-16/h2-10,17,19-20,22H,11-14H2,1H3,(H,27,33)/t17-,19+,20-,22+/m1/s1 IGJBHJUWECEBGL-KHHDVDEJSA-N 355694 (2S,4R)-1-[2-(3-Acetyl-indazol-1- yl)-acetyl]-4-fluoro-pyrrolidine-2- carboxylic acid ((1R,2S)-2-phenyl- cyclopropyl)-amide::US9815819, 59 Complement factor D Human 37.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355694&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073506 386395306 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703392 CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2)c2ccccc12 InChI=1S/C25H25FN4O3/c1-15(31)24-18-9-5-6-10-21(18)30(28-24)14-23(32)29-13-17(26)11-22(29)25(33)27-20-12-19(20)16-7-3-2-4-8-16/h2-10,17,19-20,22H,11-14H2,1H3,(H,27,33)/t17-,19-,20+,22+/m1/s1 IGJBHJUWECEBGL-PBVWOCPUSA-N 355695 (2S,4R)-1-[2-(3-Acetyl-indazol-1- yl)-acetyl]-4-fluoro-pyrrolidine-2- carboxylic acid ((1S,2R)-2-phenyl- cyclopropyl)-amide::US9815819, 60 Complement factor D Human 294 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355695&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073491 386395307 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703393 CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2)c2ccccc12 InChI=1S/C26H26N4O3/c1-15(31)24-18-9-5-6-10-22(18)30(28-24)14-23(32)29-13-17-11-20(17)25(29)26(33)27-21-12-19(21)16-7-3-2-4-8-16/h2-10,17,19-21,25H,11-14H2,1H3,(H,27,33)/t17-,19-,20-,21+,25+/m1/s1 YVUFOXCGFFISLD-VQMCVSMBSA-N 355696 (1R,2S,5S)-3-[2-(3-Acetyl-indazol- 1-yl)-acetyl]-3-aza- bicyclo[3.1.0]hexane-2-carboxylic acid ((1S,2R)-2-phenyl- cyclopropyl)-amide::US9815819, 61 Complement factor D Human 776 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355696&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943470 386395308 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703394 CC(=O)c1nn(CC(=O)N2C[C@H]3C[C@H]3[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2)c2ccccc12 InChI=1S/C26H26N4O3/c1-15(31)24-18-9-5-6-10-22(18)30(28-24)14-23(32)29-13-17-11-20(17)25(29)26(33)27-21-12-19(21)16-7-3-2-4-8-16/h2-10,17,19-21,25H,11-14H2,1H3,(H,27,33)/t17-,19+,20-,21-,25+/m1/s1 YVUFOXCGFFISLD-ZBKKKRSOSA-N 355697 (1R,2S,5S)-3-[2-(3-Acetyl-indazol- 1-yl)-acetyl]-3-aza- bicyclo[3.1.0]hexane-2-carboxylic acid ((1R,2S)-2-phenyl- cyclopropyl)-amide::US9815819, 62 Complement factor D Human 131 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355697&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943471 386395309 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703395 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2F)c2ncccc12 InChI=1S/C25H24FN5O3/c1-13(32)23-16-6-4-8-27-24(16)30(29-23)12-22(33)31-20-9-14(20)10-21(31)25(34)28-19-11-17(19)15-5-2-3-7-18(15)26/h2-8,14,17,19-21H,9-12H2,1H3,(H,28,34)/t14-,17+,19-,20-,21+/m1/s1 RQPZCVOEJLKTMJ-FHBRLQHDSA-N 355698 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid [(1R,2S)-2-(2- fluoro-phenyl)-cyclopropyl]-amide::US9815819, 63 Complement factor D Human 64.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355698&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073497 386395310 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703396 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2F)c2ncccc12 InChI=1S/C25H24FN5O3/c1-13(32)23-16-6-4-8-27-24(16)30(29-23)12-22(33)31-20-9-14(20)10-21(31)25(34)28-19-11-17(19)15-5-2-3-7-18(15)26/h2-8,14,17,19-21H,9-12H2,1H3,(H,28,34)/t14-,17-,19+,20-,21+/m1/s1 RQPZCVOEJLKTMJ-VJXVFPJBSA-N 355699 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid [(1S,2R)-2-(2- fluoro-phenyl)-cyclopropyl]-amide::US9815819, 64 Complement factor D Human 791 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355699&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073493 386395311 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703397 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2cnccc12 InChI=1S/C25H24ClN5O3/c1-13(32)24-16-6-7-27-11-22(16)30(29-24)12-23(33)31-20-8-14(20)9-21(31)25(34)28-19-10-17(19)15-4-2-3-5-18(15)26/h2-7,11,14,17,19-21H,8-10,12H2,1H3,(H,28,34)/t14-,17+,19-,20-,21+/m1/s1 NYQUEBDZEWXHRS-FHBRLQHDSA-N 355700 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid [(1R,2S)-2-(2- chloro-phenyl)-cyclopropyl]-amide::US9815819, 65 Complement factor D Human 30.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355700&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073395 386395312 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703398 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2ncccc12 InChI=1S/C25H24ClN5O3/c1-13(32)23-16-6-4-8-27-24(16)30(29-23)12-22(33)31-20-9-14(20)10-21(31)25(34)28-19-11-17(19)15-5-2-3-7-18(15)26/h2-8,14,17,19-21H,9-12H2,1H3,(H,28,34)/t14-,17+,19-,20-,21+/m1/s1 NEQUYRBLOORVCJ-FHBRLQHDSA-N 355701 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-b]pyridin-1-yl)-acetyl]- 2-aza-bicyclo[3.1.0] hexane-3- carboxylic acid [(1R,2S)-2-(2- chloro-phenyl)-cyclopropyl]-amide::US9815819, 66 Complement factor D Human 44.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355701&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073461 386395313 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703399 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2Cl)c2cnccc12 InChI=1S/C24H23ClN6O3/c25-16-4-2-1-3-13(16)15-9-17(15)28-24(34)19-8-12-7-18(12)31(19)21(32)11-30-20-10-27-6-5-14(20)22(29-30)23(26)33/h1-6,10,12,15,17-19H,7-9,11H2,(H2,26,33)(H,28,34)/t12-,15+,17-,18-,19+/m1/s1 SRUVQNXKBMRRSH-SHXNRTNRSA-N 355702 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2- Chloro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-pyrazolo[3,4-c]pyridine- 3-carboxylic acid amide::US9815819, 67 Complement factor D Human 35.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355702&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019387 386395314 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703400 CCc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3Cl)c2cn1)C(N)=O InChI=1S/C26H27ClN6O3/c1-2-14-9-17-22(11-29-14)32(31-24(17)25(28)35)12-23(34)33-20-7-13(20)8-21(33)26(36)30-19-10-16(19)15-5-3-4-6-18(15)27/h3-6,9,11,13,16,19-21H,2,7-8,10,12H2,1H3,(H2,28,35)(H,30,36)/t13-,16+,19-,20-,21+/m1/s1 UEDKJXUARJQEGU-LSVMVFPXSA-N 355703 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2- Chloro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-5-ethyl-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 68 Complement factor D Human 37.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355703&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019431 386395315 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703401 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@H]2C[C@@H]2c2ccccc2Cl)c2ccccc12 InChI=1S/C25H24ClN5O3/c26-17-7-3-1-5-14(17)16-11-18(16)28-25(34)21-10-13-9-20(13)31(21)22(32)12-30-19-8-4-2-6-15(19)23(29-30)24(27)33/h1-8,13,16,18,20-21H,9-12H2,(H2,27,33)(H,28,34)/t13-,16-,18+,20-,21+/m1/s1 UXVZINSCKZBLGX-JLJUSWPRSA-N 355704 1-(2-{(1R,3S,5R)-3-[(1S,2R)-2-(2- Chloro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-indazole-3-carboxylic acid amide::US9815819, 69 Complement factor D Human 764 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355704&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90020054 386395316 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703402 Cc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3F)c2cn1)C(N)=O InChI=1S/C25H25FN6O3/c1-12-6-16-21(10-28-12)31(30-23(16)24(27)34)11-22(33)32-19-7-13(19)8-20(32)25(35)29-18-9-15(18)14-4-2-3-5-17(14)26/h2-6,10,13,15,18-20H,7-9,11H2,1H3,(H2,27,34)(H,29,35)/t13-,15+,18-,19-,20+/m1/s1 LCOYLKNLLGWZQW-ZWIPKVPUSA-N 355705 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2- Fluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-5-methyl-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 70 Complement factor D Human 125 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355705&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019265 386395317 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703403 Cc1cc2c(nn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3F)c2cn1)C(N)=O InChI=1S/C24H24F2N6O3/c1-12-6-16-20(9-28-12)32(30-22(16)23(27)34)11-21(33)31-10-13(25)7-19(31)24(35)29-18-8-15(18)14-4-2-3-5-17(14)26/h2-6,9,13,15,18-19H,7-8,10-11H2,1H3,(H2,27,34)(H,29,35)/t13-,15+,18-,19+/m1/s1 OSMVBGFWMJKWDJ-MWLKLMTCSA-N 355706 1-(2-{(2S,4R)-4-Fluoro-2-[(1R,2S)- 2-(2-fluoro-phenyl)- cyclopropylcarbamoyl]-pyrrolidin- 1-yl}-2-oxo-ethyl)-5-methyl-1H- pyrazolo[3,4-c]pyridine-3- carboxylic acid amide::US9815819, 71 Complement factor D Human 90.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355706&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90020165 386395318 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703404 NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccc(Cl)cc2)c2cnccc12 InChI=1S/C23H22ClFN6O3/c24-13-3-1-12(2-4-13)16-8-17(16)28-23(34)18-7-14(25)10-30(18)20(32)11-31-19-9-27-6-5-15(19)21(29-31)22(26)33/h1-6,9,14,16-18H,7-8,10-11H2,(H2,26,33)(H,28,34)/t14-,16+,17-,18+/m1/s1 NXDAAWAJWFCSTJ-SPUZQDLCSA-N 355707 1-(2-{(2S,4R)-2-[(1R,2S)-2-(4- Chloro-phenyl)- cyclopropylcarbamoyl]-4-fluoro- pyrrolidin-1-yl}-2-oxo-ethyl)-1H- pyrazolo[3,4-c]pyridine-3- carboxylic acid amide::US9815819, 72 Complement factor D Human 309 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355707&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943718 386395319 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703405 Cc1cc2c(nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)N[C@@H]3C[C@H]3c3ccccc3Cl)c2cn1)C(N)=O InChI=1S/C25H25ClN6O3/c1-12-6-16-21(10-28-12)31(30-23(16)24(27)34)11-22(33)32-19-7-13(19)8-20(32)25(35)29-18-9-15(18)14-4-2-3-5-17(14)26/h2-6,10,13,15,18-20H,7-9,11H2,1H3,(H2,27,34)(H,29,35)/t13-,15+,18-,19-,20+/m1/s1 PBJRNVTTZQANOX-ZWIPKVPUSA-N 355708 1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2- Chloro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-5-methyl-1H-pyrazolo[3,4- c]pyridine-3-carboxylic acid amide::US9815819, 73 Complement factor D Human 45.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355708&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90020406 386395320 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703406 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2ccc(F)cc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-13-5-6-14(17(27)9-13)16-10-18(16)29-25(35)21-8-12-7-20(12)32(21)22(33)11-31-19-4-2-1-3-15(19)23(30-31)24(28)34/h1-6,9,12,16,18,20-21H,7-8,10-11H2,(H2,28,34)(H,29,35)/t12-,16?,18?,20-,21+/m1/s1 LFWWHVWFUBRYKQ-KOGRAGSHSA-N 355709 1-(2-{(1R,3S,5R)-3-[2-(2,4- Difluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-indazole-3-carboxylic acid amideDia 1::US9815819, 74::US9815819, 75::US9815819, 76::US9815819, 77 Complement factor D Human 3760 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355709&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 132122964 386395321 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703407 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2ccc(F)cc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-13-5-6-14(17(27)9-13)16-10-18(16)29-25(35)21-8-12-7-20(12)32(21)22(33)11-31-19-4-2-1-3-15(19)23(30-31)24(28)34/h1-6,9,12,16,18,20-21H,7-8,10-11H2,(H2,28,34)(H,29,35)/t12-,16?,18?,20-,21+/m1/s1 LFWWHVWFUBRYKQ-KOGRAGSHSA-N 355709 1-(2-{(1R,3S,5R)-3-[2-(2,4- Difluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-indazole-3-carboxylic acid amideDia 1::US9815819, 74::US9815819, 75::US9815819, 76::US9815819, 77 Complement factor D Human 7760 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355709&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 132122964 386395321 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703408 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2ccc(F)cc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-13-5-6-14(17(27)9-13)16-10-18(16)29-25(35)21-8-12-7-20(12)32(21)22(33)11-31-19-4-2-1-3-15(19)23(30-31)24(28)34/h1-6,9,12,16,18,20-21H,7-8,10-11H2,(H2,28,34)(H,29,35)/t12-,16?,18?,20-,21+/m1/s1 LFWWHVWFUBRYKQ-KOGRAGSHSA-N 355709 1-(2-{(1R,3S,5R)-3-[2-(2,4- Difluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-indazole-3-carboxylic acid amideDia 1::US9815819, 74::US9815819, 75::US9815819, 76::US9815819, 77 Complement factor D Human 36.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355709&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 132122964 386395321 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703409 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2ccc(F)cc2F)c2ccccc12 InChI=1S/C25H23F2N5O3/c26-13-5-6-14(17(27)9-13)16-10-18(16)29-25(35)21-8-12-7-20(12)32(21)22(33)11-31-19-4-2-1-3-15(19)23(30-31)24(28)34/h1-6,9,12,16,18,20-21H,7-8,10-11H2,(H2,28,34)(H,29,35)/t12-,16?,18?,20-,21+/m1/s1 LFWWHVWFUBRYKQ-KOGRAGSHSA-N 355709 1-(2-{(1R,3S,5R)-3-[2-(2,4- Difluoro-phenyl)- cyclopropylcarbamoyl]-2-aza- bicyclo[3.1.0]hex-2-yl}-2-oxo- ethyl)-1H-indazole-3-carboxylic acid amideDia 1::US9815819, 74::US9815819, 75::US9815819, 76::US9815819, 77 Complement factor D Human 640 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355709&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 132122964 386395321 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703410 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCCC(C2)c2ccccc2)c2ccccc12 InChI=1S/C28H31N5O3/c29-27(35)26-21-11-4-5-12-22(21)32(31-26)16-25(34)33-23-14-19(23)15-24(33)28(36)30-20-10-6-9-18(13-20)17-7-2-1-3-8-17/h1-5,7-8,11-12,18-20,23-24H,6,9-10,13-16H2,(H2,29,35)(H,30,36)/t18?,19-,20?,23-,24+/m1/s1 QHZNSUVGWSMLDQ-HCHHUPERSA-N 355713 1-{2-Oxo-2-[(1R,3S,5R)-3-(3- phenyl-cyclohexylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 78::US9815819, 79::US9815819, 80::US9815819, 81 Complement factor D Human 2004 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355713&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073417 386395322 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703411 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCCC(C2)c2ccccc2)c2ccccc12 InChI=1S/C28H31N5O3/c29-27(35)26-21-11-4-5-12-22(21)32(31-26)16-25(34)33-23-14-19(23)15-24(33)28(36)30-20-10-6-9-18(13-20)17-7-2-1-3-8-17/h1-5,7-8,11-12,18-20,23-24H,6,9-10,13-16H2,(H2,29,35)(H,30,36)/t18?,19-,20?,23-,24+/m1/s1 QHZNSUVGWSMLDQ-HCHHUPERSA-N 355713 1-{2-Oxo-2-[(1R,3S,5R)-3-(3- phenyl-cyclohexylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 78::US9815819, 79::US9815819, 80::US9815819, 81 Complement factor D Human 114 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355713&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073417 386395322 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703412 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCCC(C2)c2ccccc2)c2ccccc12 InChI=1S/C28H31N5O3/c29-27(35)26-21-11-4-5-12-22(21)32(31-26)16-25(34)33-23-14-19(23)15-24(33)28(36)30-20-10-6-9-18(13-20)17-7-2-1-3-8-17/h1-5,7-8,11-12,18-20,23-24H,6,9-10,13-16H2,(H2,29,35)(H,30,36)/t18?,19-,20?,23-,24+/m1/s1 QHZNSUVGWSMLDQ-HCHHUPERSA-N 355713 1-{2-Oxo-2-[(1R,3S,5R)-3-(3- phenyl-cyclohexylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 78::US9815819, 79::US9815819, 80::US9815819, 81 Complement factor D Human 475 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355713&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073417 386395322 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703413 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCCC(C2)c2ccccc2)c2ccccc12 InChI=1S/C28H31N5O3/c29-27(35)26-21-11-4-5-12-22(21)32(31-26)16-25(34)33-23-14-19(23)15-24(33)28(36)30-20-10-6-9-18(13-20)17-7-2-1-3-8-17/h1-5,7-8,11-12,18-20,23-24H,6,9-10,13-16H2,(H2,29,35)(H,30,36)/t18?,19-,20?,23-,24+/m1/s1 QHZNSUVGWSMLDQ-HCHHUPERSA-N 355713 1-{2-Oxo-2-[(1R,3S,5R)-3-(3- phenyl-cyclohexylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-indazole-3-carboxylic acid amideDia 1::US9815819, 78::US9815819, 79::US9815819, 80::US9815819, 81 Complement factor D Human 5653 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355713&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073417 386395322 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703414 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CCCC(C2)c2ccccc2)c2cnccc12 InChI=1S/C27H30N6O3/c28-26(35)25-20-9-10-29-14-23(20)32(31-25)15-24(34)33-21-12-18(21)13-22(33)27(36)30-19-8-4-7-17(11-19)16-5-2-1-3-6-16/h1-3,5-6,9-10,14,17-19,21-22H,4,7-8,11-13,15H2,(H2,28,35)(H,30,36)/t17?,18-,19?,21-,22+/m1/s1 KTCYDLCEZQOKFV-IRCYLWAESA-N 355717 1-{2-Oxo-2-[(1R,3S,5R)-3-(3- phenyl-cyclohexylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amideDia 2::US9815819, 82 Complement factor D Human 230 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355717&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 90019455 386395323 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703415 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC[C@@H](C2)c2ccccc2)c2cnccc12 InChI=1S/C26H28N6O3/c27-25(34)24-19-8-9-28-13-22(19)31(30-24)14-23(33)32-20-11-17(20)12-21(32)26(35)29-18-7-6-16(10-18)15-4-2-1-3-5-15/h1-5,8-9,13,16-18,20-21H,6-7,10-12,14H2,(H2,27,34)(H,29,35)/t16-,17+,18?,20+,21-/m0/s1 SRBUSBKCBWFLNZ-YKOZRFEGSA-N 355718 1-{2-Oxo-2-[(1R,3S,5R)-3-((S)-3- phenyl-cyclopentylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amideDia 1::US9815819, 83::US9815819, 84 Complement factor D Human 1292 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355718&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073421 386395324 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703416 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC[C@@H](C2)c2ccccc2)c2cnccc12 InChI=1S/C26H28N6O3/c27-25(34)24-19-8-9-28-13-22(19)31(30-24)14-23(33)32-20-11-17(20)12-21(32)26(35)29-18-7-6-16(10-18)15-4-2-1-3-5-15/h1-5,8-9,13,16-18,20-21H,6-7,10-12,14H2,(H2,27,34)(H,29,35)/t16-,17+,18?,20+,21-/m0/s1 SRBUSBKCBWFLNZ-YKOZRFEGSA-N 355718 1-{2-Oxo-2-[(1R,3S,5R)-3-((S)-3- phenyl-cyclopentylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amideDia 1::US9815819, 83::US9815819, 84 Complement factor D Human 1454 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355718&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073421 386395324 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703417 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC[C@H](C2)c2ccccc2)c2cnccc12 InChI=1S/C26H28N6O3/c27-25(34)24-19-8-9-28-13-22(19)31(30-24)14-23(33)32-20-11-17(20)12-21(32)26(35)29-18-7-6-16(10-18)15-4-2-1-3-5-15/h1-5,8-9,13,16-18,20-21H,6-7,10-12,14H2,(H2,27,34)(H,29,35)/t16-,17-,18?,20-,21+/m1/s1 SRBUSBKCBWFLNZ-KWJOIHEDSA-N 355720 1-{2-Oxo-2-[(1R,3S,5R)-3-((R)-3- phenyl-cyclopentylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amideDia 1::US9815819, 85::US9815819, 86 Complement factor D Human 1231 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355720&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073466 386395325 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703418 NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC[C@H](C2)c2ccccc2)c2cnccc12 InChI=1S/C26H28N6O3/c27-25(34)24-19-8-9-28-13-22(19)31(30-24)14-23(33)32-20-11-17(20)12-21(32)26(35)29-18-7-6-16(10-18)15-4-2-1-3-5-15/h1-5,8-9,13,16-18,20-21H,6-7,10-12,14H2,(H2,27,34)(H,29,35)/t16-,17-,18?,20-,21+/m1/s1 SRBUSBKCBWFLNZ-KWJOIHEDSA-N 355720 1-{2-Oxo-2-[(1R,3S,5R)-3-((R)-3- phenyl-cyclopentylcarbamoyl)-2- aza-bicyclo[3.1.0]hex-2-yl]-ethyl}- 1H-pyrazolo[3,4-c]pyridine-3- carboxylic acid amideDia 1::US9815819, 85::US9815819, 86 Complement factor D Human 648 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355720&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 118073466 386395325 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4 703419 CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)N[C@@H]2C[C@H]2c2ccccc2F)c2cc(ccc12)C(O)=O InChI=1S/C27H25FN4O5/c1-13(33)25-17-7-6-14(27(36)37)8-22(17)31(30-25)12-24(34)32-21-9-15(21)10-23(32)26(35)29-20-11-18(20)16-4-2-3-5-19(16)28/h2-8,15,18,20-21,23H,9-12H2,1H3,(H,29,35)(H,36,37)/t15-,18+,20-,21-,23+/m1/s1 IEPNCKARVUJHDN-YWPLBBIESA-N 355722 3-Acetyl-1-(2-{(1R,3S,5R)-3-[(1R,2S)-2-(2-fluoro-phenyl)-cyclopropylcarbamoyl]-2-aza-bicyclo[3.1.0]hex-2-yl}-2-oxo-ethyl)-1H-indazole-6-carboxylic acid::US9815819, 87 Complement factor D Human 46.0 US Patent 10.7270/Q2QF8W1V aid1797604 US9815819 Altmann, E; Hommel, U; Lorthiois, EL; Maibaum, JK; Ostermann, N; Quancard, J; Randl, SA; Rogel, O; Vulpetti, A 11/14/2017 10/13/2019 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=355722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=355722&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search 72943943 386395326 1 MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA 1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6 Complement factor D CFAD_HUMAN P00746 B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4